LeadStory

Scripps News

FDA weighs warning labels on antidepressants for pregnant women

Scripps News · Recent
Scripps News
Scripps News
Recent

The president of the American College of Obstetricians and Gynecologists said the claims were "outlandish and unfounded" and will "only serve to incite fear."

Breakdown
  • FDA is considering adding warning labels to antidepressants for pregnant women.
  • Medical consensus holds that antidepressants are generally safe during pregnancy. 9s
  • An advisory panel raised concerns about possible risks including autism, miscarriage, and birth defects. 14s
  • Johns Hopkins reports antidepressants are not known to cause birth defects, but about 30% of exposed babies may experience neonatal adaptation syndrome. 24s
  • Experts warn that untreated depression in mothers poses significant risks, as mental health conditions are the leading cause of pregnancy-related deaths. 40s
HealthPregnancy